The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
p63 and p73 in human cancer: defining the network
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: p73α Regulation by Chk1 in Response to DNA Damage
González, S., Prives, C. L., & Cordon‐Cardo, C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8161-8171.2003 · Cited by 83
RetractedMolecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 2×
“The p53 tumor suppressor functions as a key nodal point that integrates upstream signals and directs the response to DNA damage, oncogenic stress and other cellular stress conditions (Vogelstein et al., 2000; Vousden, 2000).”
Backgroundp63 is essential for regenerative proliferation in limb, craniofacial and epithelial development
Yang, A., Schweitzer, R., Sun, D., Kaghad, M., Walker, N., Bronson, R. T., Tabin, C., Sharpe, A., Caput, D., Crum, C., et al. (1999) · Nature · doi:10.1038/19539 · Cited by 2,225
Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain
Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206
Yang, A., Kaghad, M., Wang, Y., Gillett, E., Fleming, M. D., Dötsch, V., Andrews, N. C., Caput, D., & McKeon, F. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80275-0 · Cited by 2,085
p63 is a p53 homologue required for limb and epidermal morphogenesis
Mills, A. A., Zheng, B., Wang, X.-J., Vogel, H., Roop, D. R., & Bradley, A. (1999) · Nature · doi:10.1038/19531 · Cited by 1,988
Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J.-C., Valent, A., Minty, A., Chalon, P., Lelias, J.-M., Dumont, X., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80540-1 · Cited by 1,637
p53 mutant mice that display early ageing-associated phenotypes
Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., et al. (2002) · Nature · doi:10.1038/415045a · Cited by 1,459 · cited 1×
“This phenotype was reminiscent of that induced following germline expression of a hypermorphic mutant p53 (Tyner et al., 2002), and was seemingly the opposite of the phenotype expected following loss of a tumor suppressor.”
BackgroundInfluentialGain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
Lang, G. A., Iwakuma, T., Suh, Y.-A., Liu, G., Rao, V. A., Parant, J. M., Valentin-Vega, Y. A., Terzian, T., Caldwell, L. C., Strong, L. C., et al. (2004) · Cell · doi:10.1016/j.cell.2004.11.006 · Cited by 1,069 · cited 1×
“In a mouse model, germline knock-in of the p53R175H DBD mutation enhanced cellular transformation through an inhibitory effect on p63 and p73 (Lang et al., 2004).”
BackgroundYang, A., Walker, N., Bronson, R., Kaghad, M., Oosterwegel, M., Bonnin, J., Vagner, C., Bonnet, H., Dikkes, P., Sharpe, A., et al. (2000) · Nature · doi:10.1038/35003607 · Cited by 990
The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage
Gong, J., Costanzo, A., Yang, H.-Q., Melino, G., Kaelin, W. G., Levrero, M., & Wang, J. Y. J. (1999) · Nature · doi:10.1038/21690 · Cited by 930
Basu, S., Totty, N. F., Irwin, M. S., Sudol, M., & Downward, J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(02)00776-1 · Cited by 843 · cited 3×
“AKT-dependent inhibition of TAp73a involves phosphorylation of YAP, which promotes association of YAP with 14-3-3 and subsequent nuclear export (Basu et al., 2003).”
Backgroundp53 isoforms can regulate p53 transcriptional activity
Bourdon, J.-C., Fernandes, K., Murray-Zmijewski, F., Liu, G., Diot, A., Xirodimas, D. P., Saville, M. K., & Lane, D. P. (2005) · Genes & Development · doi:10.1101/gad.1339905 · Cited by 810
p63 and p73 are required for p53-dependent apoptosis in response to DNA damage
Flores, E. R., Tsai, K. Y., Crowley, D., Sengupta, S., Yang, A., McKeon, F., & Jacks, T. (2002) · Nature · doi:10.1038/416560a · Cited by 802
Vousden, K. H. (2000) · Cell · doi:10.1016/s0092-8674(00)00171-9 · Cited by 790
Role for the p53 homologue p73 in E2F-1-induced apoptosis
Irwin, M., Marin, M. C., Phillips, A. C., Seelan, R. S., Smith, D. I., Liu, W., Flores, E. R., Tsai, K. Y., Jacks, T., Vousden, K. H., et al. (2000) · Nature · doi:10.1038/35036614 · Cited by 710
MDM2 — master regulator of the p53 tumor suppressor protein
Momand, J., Wu, H.-H., & Dasgupta, G. (2000) · Gene · doi:10.1016/s0378-1119(99)00487-4 · Cited by 641 · cited 1×
“MDM2 is an E3 ubiquitin ligase that functions as an essential negative regulator of p53 through ubiquitination and subsequent proteasome degradation (Momand et al., 2000).”
BackgroundP53 expression in breast cancer
Cattoretti, G., Rilke, F., Andreola, S., D'Amato, L., & Delia, D. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910410204 · Cited by 601
p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage
Yuan, Z.-M., Shioya, H., Ishiko, T., Sun, X., Gu, J., Huang, Y., Lu, H., Kharbanda, S., Weichselbaum, R., & Kufe, D. (1999) · Nature · doi:10.1038/21704 · Cited by 578
p73: Friend or foe in tumorigenesis
Melino, G., De Laurenzi, V., & Vousden, K. H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc861 · Cited by 560
p63 protects the female germ line during meiotic arrest
Suh, E.-K., Yang, A., Kettenbach, A., Bamberger, C., Michaelis, A. H., Zhu, Z., Elvin, J. A., Bronson, R. T., Crum, C. P., & McKeon, F. (2006) · Nature · doi:10.1038/nature05337 · Cited by 549
Interaction of c-Abl and p73α and their collaboration to induce apoptosis
Agami, R., Blandino, G., Oren, M., & Shaul, Y. (1999) · Nature · doi:10.1038/21697 · Cited by 546
A common polymorphism acts as an intragenic modifier of mutant p53 behaviour
Marin, M. C., Jost, C. A., Brooks, L. A., Irwin, M. S., O'Nions, J., Tidy, J. A., James, N., McGregor, J. M., Harwood, C. A., Yulug, I. G., et al. (2000) · Nature Genetics · doi:10.1038/75586 · Cited by 515
Flores, E. R., Sengupta, S., Miller, J. B., Newman, J. J., Bronson, R., Crowley, D., Yang, A., McKeon, F., & Jacks, T. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.019 · Cited by 502
On the shoulders of giants: p63, p73 and the rise of p53
Yang, A., Kaghad, M., Caput, D., & McKeon, F. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(02)02595-7 · Cited by 486
p63 and p73: Roles in Development and Tumor Formation
Moll, U. M., & Slade, N. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.371.2.7 · Cited by 486
p63 and p73: p53 mimics, menaces and more
Yang, A., & McKeon, F. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35043127 · Cited by 483
p63 regulates proliferation and differentiation of developmentally mature keratinocytes
Truong, A. B., Kretz, M., Ridky, T. W., Kimmel, R., & Khavari, P. A. (2006) · Genes & Development · doi:10.1101/gad.1463206 · Cited by 479
An Anti-Apoptotic Role for the p53 Family Member, p73, During Developmental Neuron Death
Pozniak, C. D., Radinovic, S., Yang, A., McKeon, F., Kaplan, D. R., & Miller, F. D. (2000) · Science · doi:10.1126/science.289.5477.304 · Cited by 465
Gaiddon, C., Lokshin, M., Ahn, J., Zhang, T., & Prives, C. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.5.1874-1887.2001 · Cited by 464
AIS is an oncogene amplified in squamous cell carcinoma
Hibi, K., Trink, B., Patturajan, M., Westra, W. H., Caballero, O. L., Hill, D. E., Ratovitski, E. A., Jen, J., & Sidransky, D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5462 · Cited by 463
Bergamaschi, D., Gasco, M., Hiller, L., Sullivan, A., Syed, N., Trigiante, G., Yulug, I., Merlano, M., Numico, G., Comino, A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00079-5 · Cited by 449
p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis
Rocco, J. W., Leong, C.-O., Kuperwasser, N., DeYoung, M. P., & Ellisen, L. W. (2006) · Cancer Cell · doi:10.1016/j.ccr.2005.12.013 · Cited by 433
Self-citationPhysical Interaction with Yes-associated Protein Enhances p73 Transcriptional Activity
Strano, S., Munarriz, E., Rossi, M., Castagnoli, L., Shaul, Y., Sacchi, A., Oren, M., Sudol, M., Cesareni, G., & Blandino, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010484200 · Cited by 422
p73 Function Is Inhibited by Tumor-Derived p53 Mutants in Mammalian Cells
Di Como, C. J., Gaiddon, C., & Prives, C. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1438 · Cited by 417
Chemosensitivity linked to p73 function
Irwin, M. S., Kondo, K., Marin, M. C., Cheng, L. S., Hahn, W. C., & Kaelin, W. G. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00078-3 · Cited by 408
Association of p63 with Proliferative Potential in Normal and Neoplastic Human Keratinocytes
Parsa, R., Yang, A., McKeon, F., & Green, H. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00780.x · Cited by 407
p63 regulates an adhesion programme and cell survival in epithelial cells
Carroll, D. K., Carroll, J. S., Leong, C.-O., Cheng, F., Brown, M., Mills, A. A., Brugge, J. S., & Ellisen, L. W. (2006) · Nature Cell Biology · doi:10.1038/ncb1420 · Cited by 403
Self-citationHigh-resolution genomic profiles of human lung cancer
Tonon, G., Wong, K.-K., Maulik, G., Brennan, C., Feng, B., Zhang, Y., Khatry, D. B., Protopopov, A., You, M. J., Aguirre, A. J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504126102 · Cited by 394
Covalent Modification of p73α by SUMO-1
Minty, A., Dumont, X., Kaghad, M., & Caput, D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004293200 · Cited by 388
Cross-regulation between Notch and p63 in keratinocyte commitment to differentiation
Nguyen, B.-C., Lefort, K., Mandinova, A., Antonini, D., Devgan, V., Della Gatta, G., Koster, M. I., Zhang, Z., Wang, J., di Vignano, A. T., et al. (2006) · Genes & Development · doi:10.1101/gad.1406006 · Cited by 387
The potential tumor suppressor p73 differentially regulates cellular p53 target genes.
Zhu, J., Jiang, J., Zhou, W., & Chen, X. (1998) · PubMed · Cited by 378
Two New p73 Splice Variants, γ and δ, with Different Transcriptional Activity
De Laurenzi, V., Costanzo, A., Barcaroli, D., Terrinoni, A., Falco, M., Annicchiarico-Petruzzelli, M., Levrero, M., & Melino, G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.9.1763 · Cited by 368
Strano, S., Monti, O., Pediconi, N., Baccarini, A., Fontemaggi, G., Lapi, E., Mantovani, F., Damalas, A., Citro, G., Sacchi, A., et al. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.04.008 · Cited by 360
Human ΔNp73 regulates a dominant negative feedback loop for TAp73 and p53
Grob, T. J., Novak, U., Maisse, C., Barcaroli, D., Lüthi, A. U., Pirnia, F., Hügli, B., Graber, H. U., De Laurenzi, V, Fey, M. F., et al. (2001) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400962 · Cited by 341
MDM2 suppresses p73 function without promoting p73 degradation
Zeng, X., Chen, L., Jost, C. A., Maya, R., Keller, D., Wang, X., Kaelin, W. G., Oren, M., Chen, J., & Lu, H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3257 · Cited by 334
Westfall, M. D., Mays, D. J., Sniezek, J. C., & Pietenpol, J. A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.7.2264-2276.2003 · Cited by 330
Significance of p63 amplification and overexpression in lung cancer development and prognosis.
Massion, P. P., Taflan, P. M., Rahman, S. M. J., Yildiz, P., Shyr, Y., Edgerton, M. E., Westfall, M. D., Roberts, J. R., Pietenpol, J. A., Carbone, D. P., et al. (2003) · PubMed · Cited by 320
ΔNp73, A Dominant-Negative Inhibitor of Wild-type p53 and TAp73, Is Up-regulated in Human Tumors
Zaika, A. I., Slade, N., Erster, S. H., Sansome, C., Joseph, T. W., Pearl, M., Chalas, E., & Moll, U. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020179 · Cited by 318
The ubiquitin–protein ligase Itch regulates p73 stability
Rossi, M., De Laurenzi, V., Munarriz, E., Green, D. R., Liu, Y., Vousden, K. H., Cesareni, G., & Melino, G. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600444 · Cited by 305
p63 deficiency activates a program of cellular senescence and leads to accelerated aging
Keyes, W. M., Wu, Y., Vogel, H., Guo, X., Lowe, S. W., & Mills, A. A. (2005) · Genes & Development · doi:10.1101/gad.342305 · Cited by 298
The common and distinct target genes of the p53 family transcription factors
Harms, K., Nozell, S., & Chen, X. (2004) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3304-4 · Cited by 295
Dohn, M., Zhang, S., & Chen, X. (2001) · Oncogene · doi:10.1038/sj.onc.1204427 · Cited by 294
Corn, P. G., Kuerbitz, S. J., van Noesel, M. M., Esteller, M., Compitello, N., Baylin, S. B., & Herman, J. G. (1999) · PubMed · Cited by 280
Yang, A., Zhu, Z., Kapranov, P., McKeon, F., Church, G. M., Gingeras, T. R., & Struhl, K. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.10.018 · Cited by 278
Functional regulation of p73 and p63: development and cancer
Melino, G. (2003) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.10.004 · Cited by 278
Differential expression of p63 isoforms in normal tissues and neoplastic cells
Nylander, K., Vojtesek, B., Nenutil, R., Lindgren, B., Roos, G., Zhanxiang, W., Sjöström, B., Dahlqvist, Å., & Coates, P. J. (2002) · The Journal of Pathology · doi:10.1002/path.1231 · Cited by 276
Loss of p63 Expression Is Associated with Tumor Progression in Bladder Cancer
Urist, M. J., Di Como, C. J., Lu, M.-L., Charytonowicz, E., Verbel, D., Crum, C. P., Ince, T. A., McKeon, F. D., & Cordon-Cardo, C. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64396-9 · Cited by 257
p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2
Urist, M., Tanaka, T., Poyurovsky, M. V., & Prives, C. (2004) · Genes & Development · doi:10.1101/gad.1221004 · Cited by 234
Barbieri, C. E., Tang, L. J., Brown, K. A., & Pietenpol, J. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2020 · Cited by 233
Ghioni, P., Bolognese, F., Duijf, P. H. G., van Bokhoven, H., Mantovani, R., & Guerrini, L. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.24.8659-8668.2002 · Cited by 223
The E3 ubiquitin ligase Itch controls the protein stability of p63
Rossi, M., Aqeilan, R. I., Neale, M., Candi, E., Salomoni, P., Knight, R. A., Croce, C. M., & Melino, G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603449103 · Cited by 223
p63 Expression in Breast Cancer: A Highly Sensitive and Specific Marker of Metaplastic Carcinoma
Koker, M. M., & Kleer, C. G. (2004) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000138183.97366.fd · Cited by 220
Mdm2 binds p73α without targeting degradation
Bálint, E., Bates, S., & Vousden, K. H. (1999) · Oncogene · doi:10.1038/sj.onc.1202781 · Cited by 212
Frequent alteration of p63 expression in human primary bladder carcinomas.
Park, B.-J., Lee, S. J., Kim, J. I., Lee, S., Lee, C. H., Chang, S. G., Park, J. H., & Chi, S. G. (2000) · PubMed · Cited by 209
A C-Terminal Inhibitory Domain Controls the Activity of p63 by an Intramolecular Mechanism
Serber, Z., Lai, H. C., Yang, A., Ou, H. D., Sigal, M. S., Kelly, A. E., Darimont, B. D., Duijf, P. H. G., van Bokhoven, H., McKeon, F., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.24.8601-8611.2002 · Cited by 205
Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation.
Kawano, S., Cw, M., Gombart, A., Bartram, C., Matsuo, Y., Asou, H., Sakashita, A., Said, J. W., Tatsumi, E., & Koeffler, H. P. (1999) · PubMed · doi:10.1182/blood.v94.3.1113.415k33_1113_1120 · Cited by 189
ΔNp63 induces β-catenin nuclear accumulation and signaling
Patturajan, M., Nomoto, S., Sommer, M., Fomenkov, A., Hibi, K., Zangen, R., Poliak, N., Califano, J., Trink, B., Ratovitski, E., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00057-0 · Cited by 187
van Bokhoven, H., & Brunner, H. G. (2002) · The American Journal of Human Genetics · doi:10.1086/341450 · Cited by 186
Pin1 Links the Activities of c-Abl and p300 in Regulating p73 Function
Mantovani, F., Piazza, S., Gostissa, M., Strano, S., Zacchi, P., Mantovani, R., Blandino, G., & Del Sal, G. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.05.007 · Cited by 181
Koga, F., Kawakami, S., Fujii, Y., Saito, K., Ohtsuka, Y., Iwai, A., Ando, N., Takizawa, T., Kageyama, Y., & Kihara, K. (2003) · PubMed · Cited by 181
Marker succession during the development of keratinocytes from cultured human embryonic stem cells
Green, H., Easley, K., & Iuchi, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307226100 · Cited by 180
Nakagawa, T., Takahashi, M., Ozaki, T., Watanabe, K.-I., Todo, S., Mizuguchi, H., Hayakawa, T., & Nakagawara, A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2575-2585.2002 · Cited by 178
Possible oncogenic potential of DeltaNp73: a newly identified isoform of human p73.
Ishimoto, O., Kawahara, C., Enjo, K., Obinata, M., Nukiwa, T., & Ikawa, S. (2002) · PubMed · Cited by 177
Transactivation-deficient ΔTA-p73 Inhibits p53 by Direct Competition for DNA Binding
Stiewe, T., Theseling, C. C., & Pützer, B. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200480200 · Cited by 173
Barbieri, C. E., & Pietenpol, J. A. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.11.028 · Cited by 171
Müller, M., Schilling, T., Sayan, A. E., Kairat, A., Lorenz, K., Schulze-Bergkamen, H., Oren, M., Koch, A., Tannapfel, A., Stremmel, W., et al. (2005) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401774 · Cited by 171
Chi, S.-W. (1999) · The EMBO Journal · doi:10.1093/emboj/18.16.4438 · Cited by 169
p53 Family members p63 and p73 are SAM domain‐containing proteins
Thanos, C. D., & Bowie, J. U. (1999) · Protein Science · doi:10.1110/ps.8.8.1708 · Cited by 169
Role of p73 in malignancy: tumor suppressor or oncogene?
Stiewe, T., & Pützer, B. M. (2002) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400995 · Cited by 162
Davison, T. S., Vagner, C., Kaghad, M., Ayed, A., Caput, D., & Arrowsmith, C. H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18709 · Cited by 160
How Many Mutant p53 Molecules Are Needed To Inactivate a Tetramer?
Chan, W. M., Siu, W. Y., Lau, A., & Poon, R. Y. C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.8.3536-3551.2004 · Cited by 158
Wang, T.-Y., Chen, B., Yang, Y., Chen, H., Wang, Y., Čviko, A., Quade, B. J., Sun, D., Yang, A., McKeon, F., et al. (2001) · Human Pathology · doi:10.1053/hupa.2001.24324 · Cited by 150
Transactivation-deficient p73α (p73Δexon2) inhibits apoptosis and competes with p53
Filippovitch, I., Sorokina, N., Gatei, M. H., Haupt, Y., Hobson, K., Moallem, E., Spring, K. J., Mould, M. A., McGuckin, M. A., Lavin, M. F., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204118 · Cited by 145
Oncogenes Induce and Activate Endogenous p73 Protein
Zaika, A. I., Irwin, M. S., Sansome, C., & Moll, U. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005737200 · Cited by 143
Concin, N., Becker, K., Slade, N., Erster, S. H., Mueller-Holzner, E., Ulmer, H., Daxenbichler, G., Zeimet, A. G., Zeillinger, R., Marth, C., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1060 · Cited by 138
p63 and p73 Transactivate Differentiation Gene Promoters in Human Keratinocytes
Laurenzi, V. D., Rossi, A., Terrinoni, A., Barcaroli, D., Levrero, M., Costanzo, A., Knight, R. A., Guerrieri, P., & Melino, G. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2932 · Cited by 137
Choi, H.-R., Batsakis, J. G., Zhan, F., Sturgis, E. M., Luna, M. A., & El‐Naggar, A. K. (2002) · Human Pathology · doi:10.1053/hupa.2002.30722 · Cited by 135
Tumor-Specific p73 Up-regulation Mediates p63 Dependence in Squamous Cell Carcinoma
DeYoung, M. P., Johannessen, C. M., Leong, C., Faquin, W. C., Rocco, J. W., & Ellisen, L. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1619 · Cited by 133
Self-citationDominant Negative p63 Isoform Expression in Head and Neck Squamous Cell Carcinoma
Sniezek, J. C., Matheny, K. E., Westfall, M. D., & Pietenpol, J. A. (2004) · The Laryngoscope · doi:10.1097/01.mlg.0000149437.35855.4b · Cited by 132
Kovalev, S., Marchenko, N. D., Swendeman, S. L., LaQuaglia, M. P., & Moll, U. M. (1998) · PubMed · Cited by 131
Evolution of Functions within the p53/p63/p73 Family
Laurenzi, V. D., & Melino, G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05602.x · Cited by 130
DNA gains in 3q occur frequently in squamous cell carcinoma of the lung, but not in adenocarcinoma
Björkqvist, A., Husgafvel‐Pursiainen, K., Anttila, S., Karjalainen, A., Tammilehto, L., Mattson, K., Vainio, H., & Knuutila, S. (1998) · Genes Chromosomes and Cancer · Cited by 128
Fontemaggi, G., Gurtner, A., Strano, S., Higashi, Y., Sacchi, A., Piaggio, G., & Blandino, G. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.24.8461-8470.2001 · Cited by 127
Elevated expression of p63 protein in human esophageal squamous cell carcinomas
Hu, H., Xia, S., Li, A., Xu, X., Cai, Y., Han, Y., Wei, F., Chen, B., Huang, X., Han, Y., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10739 · Cited by 123
Hagiwara, K., McMenamin, M. G., Miura, K., & Harris, C. C. (1999) · PubMed · Cited by 122
Redon, R., Muller, D., Caulee, K., Wanherdrick, K., Abecassis, J., & du Manoir, S. (2001) · PubMed · Cited by 118
Fomenkov, A. I., Zangen, R., Huang, Y., Osada, M., Guo, Z., Fomenkov, T., Trink, B., Sidransky, D., & Ratovitski, E. A. (2004) · Cell Cycle · doi:10.4161/cc.3.10.1155 · Cited by 117
P63 Is an Essential Proapoptotic Protein during Neural Development
Jacobs, W. B., Govoni, G. R., Ho, D. K., Atwal, J. K., Barnabé‐Heider, F., Keyes, W. M., Mills, A. A., Miller, F. D., & Kaplan, D. R. (2005) · Neuron · doi:10.1016/j.neuron.2005.10.027 · Cited by 117
Helton, E. S., Zhu, J., & Chen, X. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507964200 · Cited by 114
E1A Activates Transcription of p73 and Noxa to Induce Apoptosis
Flinterman, M., Guelen, L., Ezzati-Nik, S., Killick, R., Melino, G., Tominaga, K., Mymryk, J. S., Gäken, J. A., & Tavassoli, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406661200 · Cited by 113
Domínguez, G., García, J. M., Peña, C., Silva, J., García‐Barberán, V., Martínez, L., Maximiano, C., Gomez, M. E., Rivera, J. A., García-Andrade, C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.2350 · Cited by 112
Shiraiwa, T., Kaneto, H., Miyatsuka, T., Kato, K., Yamamoto, K., Kawashima, A., Kanda, T., Suzuki, M., Imano, E., Matsuhisa, M., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.158 · Cited by 109
p53 family members in myogenic differentiation and rhabdomyosarcoma development
Çam, H., Griesmann, H., Beitzinger, M., Hofmann, L., Beinoravičiūtė-Kellner, R., Sauer, M., Hüttinger-Kirchhof, N., Oswald, C., Friedl, P., Gattenlöhner, S., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.024 · Cited by 109
ΔNp73β Is Active in Transactivation and Growth Suppression
Liu, G., Nozell, S. E., Xiao, H., & Chen, X. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.24.2.487-501.2004 · Cited by 109
p63: oncogene or tumor suppressor?
Mills, A. A. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.12.001 · Cited by 107
Petrenko, O., Zaika, A. I., & Moll, U. M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.16.5540-5555.2003 · Cited by 105
Miyazaki, K., Ozaki, T., Kato, C., Hanamoto, T., Fujita, T., Irino, S., Watanabe, K., Nakagawa, T., & Nakagawara, A. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01347-0 · Cited by 103
p53 protein variants: structural and functional similarities with p63 and p73 isoforms
Courtois-Cox, S., de Fromentel, C. C., & Hainaut, P. L. (2004) · Oncogene · doi:10.1038/sj.onc.1206929 · Cited by 102
The Protein Stability and Transcriptional Activity of p63α are Regulated by SUMO-1 Conjugation
Ghioni, P., D’Alessandra, Y., Mansueto, G., Jaffray, E., Hay, R. T., Mantia, G. L., & Guerrini, L. (2004) · Cell Cycle · doi:10.4161/cc.4.1.1359 · Cited by 101
Induction of p57 KIP2 expression by p73β
Bálint, É., Phillips, A. C., Козлов, С. В., Stewart, C. L., & Vousden, K. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062491899 · Cited by 97
Senoo, M., Matsumura, Y., & Habu, S. (2002) · Oncogene · doi:10.1038/sj.onc.1205330 · Cited by 95
Calabrò, V., Mansueto, G., Parisi, T., Vivo, M., Calogero, R., & Mantia, G. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107173200 · Cited by 94
p73 Interacts with c-Myc to Regulate Y-box-binding Protein-1 Expression
Uramoto, H., Izumi, H., Ise, T., Tada, M., Uchiumi, T., Kuwano, M., Yasumoto, K., Funa, K., & Kohno, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200266200 · Cited by 92
The Survival of Antigen-Stimulated T Cells Requires NFκB-Mediated Inhibition of p73 Expression
Wan, Y. Y., & DeGregori, J. V. (2003) · Immunity · doi:10.1016/s1074-7613(03)00053-0 · Cited by 89
p63 heterozygous mutant mice are not prone to spontaneous or chemically induced tumors
Keyes, W. M., Vogel, H. S., Koster, M. I., Guo, X., Qi, Y., Petherbridge, K. M., Roop, D. R., Bradley, A., & Mills, A. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602477103 · Cited by 88
Harmes, D. C., Bresnick, E., Lubin, E. A., Watson, J. K., Heim, K. E., Curtin, J. C., Suskind, A. M., Lamb, J., & DiRenzo, J. (2003) · Oncogene · doi:10.1038/sj.onc.1207129 · Cited by 85
ΔNp63α Levels Correlate with Clinical Tumor Response to Cisplatin
Zangen, R., Ratovitski, E. A., & Sidransky, D. (2005) · Cell Cycle · doi:10.4161/cc.4.10.2066 · Cited by 84
Watanabe, K., Ozaki, T., Nakagawa, T., Miyazaki, K., Takahashi, M., Hosoda, M., Hayashi, S., Todo, S., & Nakagawara, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111281200 · Cited by 83
The expression of p73 is increased in lung cancer, independent of p53 gene alteration
Tokuchi, Y., Hashimoto, T., Kobayashi, Y., Hayashi, M., 西田, 一., Hayashi, S., Imai, K., Nakachi, K., Ishikawa, Y., Nakagawa, K., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690572 · Cited by 81
p63 and p73 are not required for the development and p53-dependent apoptosis of T cells
Senoo, M., Manis, J. P., Alt, F. W., & McKeon, F. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.005 · Cited by 81
ΔNp63α Expression Is Regulated by the Phosphoinositide 3-Kinase Pathway
Barbieri, C. E., Barton, C. E., & Pietenpol, J. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309943200 · Cited by 80
Weber, A., Bellmann, U., Bootz, F., Wittekind, C., & Tannapfel, A. (2002) · International Journal of Cancer · doi:10.1002/ijc.10296 · Cited by 79
P63 expression in normal, hyperplastic and malignant breast tissues
Wang, X., Mori, I., Tang, W., Nakamura, M., Nakamura, Y., Sato, M., Sakurai, T., & Kakudo, K. (2002) · Breast Cancer · doi:10.1007/bf02967592 · Cited by 78
Ubiquitin and Ubiquitin-Like Modifications of the p53 Family
Watson, I. R., & Irwin, M. S. (2006) · Neoplasia · doi:10.1593/neo.06439 · Cited by 77
Regulation of the p73 protein stability and degradation
Oberst, A., Rossi, M., Salomoni, P., Pandolfi, P. P., Oren, M., Melino, G., & Bernassola, F. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.158 · Cited by 76
Itch/AIP4 Associates with and Promotes p63 Protein Degradation
Rossi, M., Simone, M. C. D., Pollice, A., Santoro, R., Mantia, G. L., Guerrini, L., & Calabrò, V. (2006) · Cell Cycle · doi:10.4161/cc.5.16.2861 · Cited by 76
Antonini, D., Rossi, B., Han, R., Minichiello, A., Palma, T. D., Corrado, M., Banfi, S., Zannini, M., Brissette, J. L., & Missero, C. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.8.3308-3318.2006 · Cited by 75
IGFBP-3 Is a Direct Target of Transcriptional Regulation by ΔNp63α in Squamous Epithelium
Barbieri, C. E., Perez, C. A., Johnson, K. N., Ely, K., Billheimer, D. D., & Pietenpol, J. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3449 · Cited by 74
Ultraviolet Radiation Induces Phosphorylation and Ubiquitin-Mediated Degradation of ΔNP63α
Westfall, M. D., Joyner, A. S., Barbieri, C. E., Livingstone, M., & Pietenpol, J. A. (2005) · Cell Cycle · doi:10.4161/cc.4.5.1685 · Cited by 74
Hdmx and Mdm2 can repress transcription activation by p53 but not by p63
Little, N. A., & Jochemsen, A. G. (2001) · Oncogene · doi:10.1038/sj.onc.1204615 · Cited by 73
Elevated and biallelic expression of p73 is associated withprogression of human bladder cancer.
Chi, S., Chang, S., Lee, S., Lee, C., Kim, J. I., & Park, J. (1999) · PubMed · Cited by 71
p53 Homologue p63 Represses Epidermal Growth Factor Receptor Expression
Nishi, H., Senoo, M., Nishi, K., Murphy, B., Rikiyama, T., Matsumura, Y., Habu, S., & Johnson, A. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101241200 · Cited by 70
Gaiddon, C., Lokshin, M., Groß, I., Levasseur, D., Taya, Y., Loeffler, J., & Prives, C. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300251200 · Cited by 65
Expression of the p53 homologues p63 and p73 in multiple simultaneous gastric cancer
Tannapfel, A., Schmelzer, S., Benicke, M., Klimpfinger, M., Kohlhaw, K., Mössner, J., Engeland, K., & Wittekind, C. (2001) · The Journal of Pathology · doi:10.1002/path.947 · Cited by 63
Matheny, K. E., Barbieri, C. E., Sniezek, J. C., Arteaga, C. L., & Pietenpol, J. A. (2003) · The Laryngoscope · doi:10.1097/00005537-200306000-00004 · Cited by 61
ΔN-p73α Accumulates in Human Neuroblastic Tumors
Douc‐Rasy, S., Barrois, M., Echeynne, M., Kaghad, M., Blanc, É., Raguénez, G., Goldschneider, D., Terrier‐Lacombe, M., Hartmann, O., Moll, U. M., et al. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64883-3 · Cited by 61
Differential regulation of p63 and p73 expression
Waltermann, A., Kartasheva, N. N., & Dobbelstein, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206859 · Cited by 59
Maisse, C., Munarriz, E. R., Barcaroli, D., Melino, G., & Laurenzi, V. D. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401376 · Cited by 57
Wild Type p73 Overexpression and High-Grade Malignancy in Breast Cancer
Domínguez, G., Silva, J. M., Silva, J., Garcia, J. M., Sánchez, A., Navarro, A., Gallego, I., Provencio, M., España, P., & Bonilla, F. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1010624717311 · Cited by 57
Romano, R., Birkaya, B. G., & Sinha, S. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700297 · Cited by 55
The Human p73 Promoter: Characterization and Identification of Functional E2F Binding Sites
Seelan, R. S., Irwin, M. S., van der Stoop, P. P. M., Qian, C., Kaelin, W. G., & Liu, W. (2002) · Neoplasia · doi:10.1038/sj.neo.7900237 · Cited by 48
Peters, U. R., Tschan, M. P., Kreuzer, K., Baskaynak, G., Lass, U., Tobler, A., Fey, M. F., & Schmidt, C. A. (1999) · PubMed · Cited by 43
Wager, M., Guilhot, J., Blanc, J.-L., Ferrand, S., Milin, S., Bataille, B., Lapierre, F., Denis, S., Chantereau, T., Cj, L., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603410 · Cited by 42
p19 Interacts with and Activates p73 by Involving the MDM2 Protein
Jeong, M.-H., Bae, J., Kim, W., Yoo, S.-M., Kim, J.-W., Song, P. I., & Choi, K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513853200 · Cited by 34
Rizzo, M. G., Giombini, E., Diverio, D., Vignetti, M., Sacchi, A., Testa, U., Lo‐Coco, F., & Blandino, G. (2004) · Leukemia · doi:10.1038/sj.leu.2403483 · Cited by 28
The Expression of P73, P21 and MDM2 Proteins in Gliomas
Kamiya, M., & Nakazato, Y. (2002) · Journal of Neuro-Oncology · doi:10.1023/a:1019633910603 · Cited by 27
Expression of TP73L is a helpful diagnostic marker of primary mediastinal large B-cell lymphomas
Zamò, A., Malpeli, G., Scarpa, A., Doglioni, C., Chilosi, M., & Menestrina, F. (2005) · Modern Pathology · doi:10.1038/modpathol.3800440 · Cited by 27
Mutation of the p51/p63 gene is associated with blastic crisis in chronic myelogenous leukemia
Yamaguchi, H., Inokuchi, K., Sakuma, Y., & Dan, K. (2001) · Leukemia · doi:10.1038/sj.leu.2402265 · Cited by 27
Hanamoto, T., Ozaki, T., Furuya, K., Hosoda, M., Hayashi, S., Nakanishi, M., Yamamoto, H., Kikuchi, H., Todo, S., & Nakagawara, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414323200 · Cited by 22
Allelic expression and quantitative RT-PCR study of TAp73 and ΔNp73 in non-Hodgkin's lymphomas
Cuadros, M., Ribas, G., Fernández, V., Rivas, C., Benitez, J. J., & Martínez–Delgado, B. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.06.024 · Cited by 9
Morrison, R. S., & Kinoshita, Y. (2000) · Science · doi:10.1126/science.289.5477.257 · Cited by 8
Cited by
When mutants gain new powers: News from the mutant p53 field
Brosh, R., & Rotter, V. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2693 · Cited by 1,132
The Chromosomal Instability Pathway in Colon Cancer
Pino, M. S., & Chung, D. C. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.065 · Cited by 932
A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis
Adorno, M., Cordenonsi, M., Montagner, M., Dupont, S., Wong, C., Hann, B., Solari, A., Bobisse, S., Rondina, M. B., Guzzardo, V., et al. (2009) · Cell · doi:10.1016/j.cell.2009.01.039 · Cited by 782
Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting
Hernández Borrero, L. J., & El-Deiry, W. S. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188556 · Cited by 748
Tumour suppression by p53: a role for the DNA damage response?
Meek, D. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2716 · Cited by 609
Metadata
- Authors
- DeYoung, M. P., & Ellisen, L. W.
- Venue
- Oncogene
- Published
- 2007-03-05
- Volume
- 26
- Issue
- 36
- Pages
- 5169-5183
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2106355114
- Cited by
- 266
- References
- 153
- FWCI
- 10.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.